NLRP3 and brain infarction: However, the expression of cleaved caspase-3 was significantly attenuated after stroke treatment with a P2X7R antagonist (BBG) or an NLRP3 inhibitor (MCC950), which significantly reduced brain infarct volume, neuronal apoptosis, and nerve damage.